Grupo Oftalmo-Biología Experimental
![Foto de Grupo Oftalmo-Biología Experimental](/img/grupo.png)
![Foto de Hospital Universitario Pío del Río Hortega](/img/noimage_org.png)
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Pío del Río Hortega (9)
2021
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
2017
-
New insights into the genetic component of non-infectious uveitis through an Immunochip strategy
Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 38-46
2015
-
Specific association of IL17A genetic variants with panuveitis
British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570
-
Study of association of CTLA4 gene variants to non-anterior uveitis
Tissue Antigens, Vol. 86, Núm. 5, pp. 373-376
2013
-
Spectral-domain optical coherence tomography study of macular structure as prognostic and determining factor for macular hole surgery outcome
Retina, Vol. 33, Núm. 6, pp. 1117-1122
2012
2010
-
Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization
Retina, Vol. 30, Núm. 10, pp. 1609-1615
2006
-
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748